PRF Technologies Ltd.
PRFXHealthcareNASDAQDrug Manufacturers - Specialty & Generic
Scan Results
Daily timeframeHeadquartered within the healthcare sector, PRF Technologies Ltd. focuses on Drug Manufacturers - Specialty & Generic services and products. PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. The $2.6M market capitalization puts PRFX squarely in micro-cap range for its industry. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia.
Market Cap
$2.6M
Beta
1.08
P/E (TTM)
—
P/E (Fwd)
-0.06
EPS (TTM)
$-4.20
EPS (Fwd)
$-12.06
ROE
-45.3%
ROA
-21.9%
Cash
$11.5M
Total Debt
$50,000
Free CF
-$2.2M
52W Change
-88.7%
Annual Financials
Cash vs Debt
Where PRFX stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, PRFX finished 52.35% below its 150-day moving average ($1.49) and 63.96% below its 200-day moving average ($1.97). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is PRFX overbought or oversold?
At the October 20, 2026 close, PRFX's RSI(14) was 15.6, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
PRF Technologies Ltd. holds $11.5M in cash against $50K in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. The company is burning cash, with free cash flow at -$2.2M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at -45.3%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits.
With cash comfortably exceeding debt, PRFX has financial flexibility that may help navigate uncertain periods. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for PRF Technologies Ltd. and its sector.